Mind Medicine Inc., a leading biotech company developing psychedelic-inspired therapies, is pleased to announce the publication of the first data on the interaction of the selective serotonin uptake inhibitor escitalopram with the acute response to psilocybin in humans.
Compound Psilocybin
Visit article
Category Press Release
Country United States of America
Companies Featured
MindMedMindMed is one of the largest companies in the psychedelics space and is developing various psychedelics for mental health disorders.